HomeBIOBV • HEL
add
Biohit Oyj
Previous close
€2.59
Day range
€2.59 - €2.70
Year range
€1.92 - €4.35
Market cap
31.65M EUR
Avg Volume
8.17K
P/E ratio
-
Dividend yield
-
Primary exchange
HEL
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 3.44M | 4.67% |
Operating expense | 1.74M | -1.61% |
Net income | 684.00K | 203.33% |
Net profit margin | 19.88 | 189.80% |
Earnings per share | — | — |
EBITDA | 678.50K | 117.12% |
Effective tax rate | 6.75% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.71M | -1.54% |
Total assets | 15.50M | 19.98% |
Total liabilities | 3.31M | -5.24% |
Total equity | 12.19M | — |
Shares outstanding | 15.18M | — |
Price to book | 3.24 | — |
Return on assets | 10.14% | — |
Return on capital | 12.30% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 684.00K | 203.33% |
Cash from operations | 1.04M | 60.22% |
Cash from investing | 40.00K | 125.81% |
Cash from financing | -65.00K | -31.31% |
Net change in cash | 987.00K | 118.60% |
Free cash flow | 250.81K | 256.71% |
About
Biohit Oyj is a Finnish company which develops, manufactures, and markets biotech and diagnostics products for use in research and health care. Wikipedia
Founded
1988
Website
Employees
46
